Cathay Biotech Inc.

688065.SS · SHH
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & EquivalentsCN¥5,347CN¥5,390CN¥6,295CN¥9,629
Short-Term InvestmentsCN¥0CN¥0CN¥0CN¥0
ReceivablesCN¥470CN¥386CN¥475CN¥275
InventoryCN¥1,181CN¥1,466CN¥1,574CN¥1,185
Other Curr. AssetsCN¥389CN¥328CN¥143CN¥305
Total Curr. AssetsCN¥7,387CN¥7,571CN¥8,475CN¥11,395
Property Plant & Equip (Net)CN¥9,849CN¥10,231CN¥6,670CN¥2,984
GoodwillCN¥0CN¥0CN¥0CN¥0
IntangiblesCN¥685CN¥704CN¥778CN¥768
Long-Term InvestmentsCN¥133CN¥143CN¥49CN¥53
Tax AssetsCN¥210CN¥159CN¥88CN¥50
Other NC AssetsCN¥757CN¥26CN¥1,767CN¥949
Total NC AssetsCN¥11,635CN¥11,263CN¥9,352CN¥4,804
Other AssetsCN¥0CN¥0CN¥0CN¥0
Total AssetsCN¥19,021CN¥18,833CN¥17,827CN¥16,198
Liabilities
PayablesCN¥1,441CN¥1,652CN¥1,060CN¥302
Short-Term DebtCN¥1,247CN¥1,531CN¥104CN¥744
Tax PayableCN¥43CN¥56CN¥36CN¥50
Deferred RevenueCN¥0CN¥13CN¥18CN¥170
Other Curr. Liab.CN¥187CN¥159CN¥143CN¥107
Total Curr. Liab.CN¥2,918CN¥3,410CN¥1,424CN¥1,218
LT DebtCN¥613CN¥245CN¥961CN¥0
Deferred Rev, NCCN¥389CN¥0CN¥404CN¥293
Deferred Tax Liab, NCCN¥0CN¥0CN¥961CN¥0
Other NC Liab.CN¥0CN¥405CN¥404CN¥0
Total NC Liab.CN¥1,003CN¥651CN¥1,365CN¥293
Other LiabilitiesCN¥0CN¥0CN¥0CN¥0
Cap. LeasesCN¥0CN¥0-CN¥63CN¥0
Total LiabilitiesCN¥3,920CN¥4,060CN¥2,789CN¥1,511
Equity
Pref StockCN¥0CN¥0CN¥0CN¥0
Common StockCN¥583CN¥583CN¥583CN¥417
Retained EarningsCN¥2,307CN¥2,069CN¥1,807CN¥1,460
AOCICN¥360CN¥226CN¥227CN¥200
Other EquityCN¥8,257CN¥8,286CN¥8,332CN¥8,588
Total EquityCN¥11,507CN¥11,164CN¥10,949CN¥10,665
Supplemental Information
Minority InterestCN¥3,594CN¥3,609CN¥4,089CN¥4,022
Total Liab. & Tot. EquityCN¥19,021CN¥18,833CN¥17,827CN¥16,198
Net Debt-CN¥3,487-CN¥3,614-CN¥5,230-CN¥8,885